Author

S. Nik-Zainal

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:DNA methylation· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

H. Davies· 3 shared X. Zou· 2 shared A. B. Brinkman· 1 shared A. Brown· 1 shared A. Butler· 1 shared A. Degasperi· 1 shared A. Ferrari· 1 shared A. Husain· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

H. Davies

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivSep 2, 2022

A living biobank of canine mammary tumor organoids as a comparative model for human breast cancer

M. Inglebert, M. Dettwiler, K. Hahn…·S. Rottenberg

This study establishes a canine mammary tumor organoid biobank to model human breast cancer, showing genetic and phenotypic conservation and utility for drug testing and CRISPR screening.

DOI 10.1038/s41598-022-21706-2

organoid / primary cultureexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJul 1, 2019

Epigenetic dysregulation underpins tumorigenesis in a cutaneous tumor syndrome.

H. Davies, K. Hodgson, E. Schwalbe…·N. Rajan

The paper identifies epigenetic mutations as drivers of tumorigenesis in CYLD cutaneous syndrome, revealing intra-tumor heterogeneity and metastatic potential.

DOI 10.1101/687459

humanwhole-exome sequencing

𝕏 PostBluesky

Cancer BiologybioRxivNov 15, 2018

Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation

A. B. Brinkman, S. Nik-Zainal, F. Simmer…·H. G. Stunnenberg

The paper shows PMDs are hypervariable in breast cancer and drive CGI hypermethylation, but do not significantly repress cancer genes.

DOI 10.1038/s41467-019-09828-0

humanDNA methylation

𝕏 PostBluesky